Matthew M. Seavey
Geen lopende functies
Profiel
Matthew M.
Seavey is currently a Senior Director-Research at Scorpius Holdings, Inc. Previously, he worked as a Director-Oncology Program at United Therapeutics Corp., a Director-Preclinical Pharmacology at CinRx Pharma LLC, and a Founding Partner at Biopoint Consulting LLC.
He holds a graduate degree from the University of Rochester, an undergraduate degree from the University of Vermont, and an MBA from West Chester University of Pennsylvania.
Eerdere bekende functies van Matthew M. Seavey
| Bedrijven | Functie | Einde |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01-02-2024 |
| Biopoint Consulting LLC | Corporate Officer/Principal | - |
CinRx Pharma LLC
 CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
Opleiding van Matthew M. Seavey
| Rochester Christian University | Graduate Degree |
| University of Vermont | Undergraduate Degree |
| West Chester University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SCORPIUS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CinRx Pharma LLC
CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Health Technology |
| Biopoint Consulting LLC |
